Johns Hopkins Psychiatry Guide
Monoamine Oxidase Inhibitors (MAOI)
INDICATIONS
FDA
FDA
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Phenelzine: bulimia nervosa, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social phobia
- Tranylcypromine: obsessive-compulsive disorder
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 23, 2025
Citation
Yang, Michelle. "Monoamine Oxidase Inhibitors (MAOI)." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787535/0/Monoamine_Oxidase_Inhibitors__MAOI_.
Yang M. Monoamine Oxidase Inhibitors (MAOI). Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787535/0/Monoamine_Oxidase_Inhibitors__MAOI_. Accessed October 8, 2025.
Yang, M. (2025). Monoamine Oxidase Inhibitors (MAOI). In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787535/0/Monoamine_Oxidase_Inhibitors__MAOI_
Yang M. Monoamine Oxidase Inhibitors (MAOI) [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787535/0/Monoamine_Oxidase_Inhibitors__MAOI_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monoamine Oxidase Inhibitors (MAOI)
ID - 787535
A1 - Yang,Michelle,Pharm.D., BCPP
Y1 - 2025/08/23/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787535/0/Monoamine_Oxidase_Inhibitors__MAOI_
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
